Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The information provided on this site includes information which are forward-looking statements within the meaning of the federal securities laws. These forward-looking statements are subject to a variety of risks and uncertainties and reflect Amnion’s current views with respect to future events and financial performance. You can identify forward-looking statements by the use of the words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “project,” “will,” “should,” and other expressions which predict or indicate future events and trends to and which do not relate to historical matters. You should not rely on forward-looking statements, because they involve known and unknown risks, uncertainties and other factors, some of which are beyond the control of the Company. These risks, uncertainties and other factors may cause the actual results, performance or achievements of the Company to be materially different from the anticipated future results, performance or achievements expressed or implied by the forward-looking statements.
Some of the factors that might cause these differences include, but are not limited to: (1) the successful integration of the businesses, multiple technologies and programs of Amnion; (2) the ability to adopt Amnion’s Triamino™ and Triamino Fulvate™ molecules to develop new, safe and effective treatments for wound care and other indications; (3) the ability to successfully complete product research and further development, including animal, preclinical and clinical studies, and commercialization of Amniogen™, and other products and Amnion’s expectations regarding market growth; (4) the cost, timing, scope and results of ongoing safety and efficacy trials of Amniogen™ and other preclinical and clinical testing; (5) the ability to negotiate strategic partnerships or other disposition transactions for Amnion’s growth initiatives; (6) the ability of Amnio to manage multiple clinical trials for a variety of product candidates; (7) the volume and profitability of product sales of Amniogen™ and other future products; (8) changes in existing and potential relationships with corporate collaborators; (9) the availability, cost, delivery and quality of clinical and commercial grade materials produced at Amnion’s own manufacturing facility or supplied by contract manufacturers and partners; (10) the timing, cost and uncertainty of obtaining potential regulatory approvals; (11) Amnion’s ability to develop and commercialize products before competitors that are superior to the alternatives developed by such competitors; (12) Amnion’s ability to retain certain members of management;(13) Amnion’s expectations regarding research and development expenses and general and administrative expenses; (14) Amnion’s expectations regarding cash balances, capital requirements, anticipated royalty payments, revenues and expenses, including infrastructure expenses; (15) the ability to obtain substantial additional funding; and (15) certain other factors that might cause Amnion’s actual results to differ materially from those in the forward-looking statements including those set forth under the headings “Business,” “Risk Factors” and Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Amnion’s Business Plan, as well as those described in Amnion’s other press releases and any governmental filings, as required from time to time. You should carefully review all of these factors, and you should be aware that there may be other factors that could cause these differences.
This site contains information concerning Amnion that may be useful to our suppliers, employees and shareholders as well as the general public. Amnion makes no representations or warranties as to the accuracy of the information contained on the site. Further, Amnion expressly disclaims any duty to do so. Amnion assumes no liability or responsibility for any errors or omissions in the content of the site or to update any forward-looking statements to reflect changes in underlying assumptions or factors, new information, future events or other changes.